Aug 10, 2022 | Advocacy, Featured
From one of the founders of the #WeAreNotWaiting” movement: “Hey FDA, if you had been listening to us, we wouldn’t have had to overwhelm you with public comments!” This is about the Fulfillment of 21st Century Cures Act Section 3060...
Jul 25, 2022 | Advocacy, Featured, Research News, Technology Updates
Experimental drug may help restore insulin-producing cells was written by Clarissa Brincat for MedicalNewsToday.com, 22 July 2022. In a recent study, the human epigenetics team at Monash University in Melbourne, Australia, found that the investigational drug GSK-126...
Jul 18, 2022 | Advocacy, Featured, Foods, Technology Updates
Diabetes Patients Flood FDA with Comments on Cybersecurity for Medical Devices, as reported by Mariam Baksh for NextGov.com, 8 July 2022. The Food and Drug Administration received more than a thousand comments—mainly from diabetes patients and their family...
Jul 11, 2022 | Advocacy, Featured, Foods, Technology Updates
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy was written by Ben Fidler for BioPharmaDive.com, 6 July 2022. The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an...
Jul 5, 2022 | Advocacy, Featured, Research News, Technology Updates
The ENTIRE Diabetes Community needs you to take action. The US FDA held a webinar on Cybersecurity in Medical Devices in June 2022, asking for feedback and comments, accepted through 7 July 2022. Time is of the ESSENCE! At issue: Unlimited,...
Jun 27, 2022 | Advocacy, Featured, Research News, Videos
4 Out Of 5 Americans With Diabetes Went Into Debt To Pay For Insulin was contributed by Deb Gordon for Forbes.com, 20 June 2022. According to a new study, released in earliy June from CharityRx, 79% of U.S. adults who have diabetes or care for someone who does...